Breaking News Instant updates and real-time market news.

SPGI

S&P Global

$270.17 /

+2.6 (+0.97%)

 09:55
04/22/20
 04/22
09:55
 04/22/20
09:55

Jefferies business services analyst to hold an analyst/industry conference call

Business Services Analyst Mazari, along with James Rieger, owner of Rieger Report, a firm that identifies valuable trends, risks and opportunities in the US Corporate and Municipal Bond Market, will discuss the impact COVID-19 has had on bond ratings and indices on an Analyst/Industry conference call to be held on April 22 at 11 am.

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 22

    Apr

  • 28

    Apr

  • 13

    May

SPGI S&P Global
$270.17 /

+2.6 (+0.97%)

03/12/20 Wells Fargo
S&P Global price target lowered to $250 from $295 at Wells Fargo
03/10/20 BMO Capital
S&P Global price target lowered to $278 from $326 at BMO Capital
02/07/20 Cantor Fitzgerald
S&P Global price target raised to $325 from $299 at Cantor Fitzgerald
01/27/20 BMO Capital
S&P Global upgraded to Outperform from Market Perform at BMO Capital

TODAY'S FREE FLY STORIES

Initiation
Gemini Therapeutics initiated with a Buy at Jefferies » 07:39
03/03/21
03/03
07:39
03/03/21
07:39
GMTX

Gemini Therapeutics

$16.05 /

+0.46 (+2.95%)

Jefferies analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMTX Gemini Therapeutics
$16.05 /

+0.46 (+2.95%)

02/10/21
Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103
02/09/21
Gemini Therapeutics appoints Brian Piekos as CFO
02/08/21
Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq
GMTX Gemini Therapeutics
$16.05 /

+0.46 (+2.95%)

03/02/21 Goldman Sachs
Gemini Therapeutics initiated with a Buy at Goldman Sachs
02/16/21 Stifel
Gemini Therapeutics initiated with a Buy at Stifel
GMTX Gemini Therapeutics
$16.05 /

+0.46 (+2.95%)

02/09/21
Five new option listings and two option delistings on February 9th
Hot Stocks
Kaleido Biosciences announces anticipated near-term milestones » 07:38
03/03/21
03/03
07:38
03/03/21
07:38
KLDO

Kaleido Biosciences

$9.56 /

-0.12 (-1.24%)

Anticipated Near-Term…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

07:38 Today
Kaleido Biosciences sees cash runway into 1Q22
01/14/21
Kaleido Biosciences announces interim results of controlled study of KB109
01/04/21
Kaleido Biosciences completes enrollment of 350 subjects in KB109 study
11/02/20
Kaleido Biosciences sees cash runway into 2H21
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
12/23/20 JMP Securities
Kaleido Biosciences initiated with an Outperform at JMP Securities
10/14/20 JPMorgan
Kaleido Biosciences resumed with an Underweight at JPMorgan
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

07:37 Today
Kaleido Biosciences reports Q4 EPS (56c), consensus (40c)
11/02/20
Kaleido Biosciences reports Q3 EPS (65c), consensus (63c)
  • 04
    Feb
  • 02
    Jun
03/17/21
Kaleido Biosciences - KLDO
03/19/21
Kaleido Biosciences
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

01/28/21
new option listings on January 28th
Hot Stocks
Dollar Tree sees FY21 store openings of 600 » 07:38
03/03/21
03/03
07:38
03/03/21
07:38
DLTR

Dollar Tree

$99.03 /

-0.16 (-0.16%)

For FY21, the company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

02/16/21
SPAR Group appoints Mike Matacunas as president, CEO
02/04/21
Instacart announces new national delivery partnership with Family Dollar
12/07/20
Dollar Tree CEO sells 12.4K shares of common stock
12/03/20
Dollar Tree Director Thomas Saunders sells almost $12M in company shares
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

02/25/21
Fly Intel: Pre-market Movers
02/25/21 BofA
BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds
02/25/21 BofA
Dollar Tree downgraded to Underperform from Buy at BofA
02/16/21 JPMorgan
Dollar Tree price target raised to $134 from $130 at JPMorgan
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

07:36 Today
Dollar Tree reports Q4 EPS $2.13, consensus $2.11
11/24/20
Dollar Tree reports Q3 EPS $1.39, consensus $1.15
11/23/20
Notable companies reporting before tomorrow's open
11/23/20
Notable companies reporting before tomorrow's open
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

02/25/21
Lowe's, Square upgrades among today's top calls on Wall Street
11/24/20
Fly Intel: Wall Street's top stories for Tuesday
11/24/20
Fly Intel: Wall Street's top stories at midday
11/24/20
Fly Intel: Pre-market Movers
09:00 Today
Dollar Tree - DLTR
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

12/16/20
Early notable gainers among liquid option names on December 16th
11/24/20
Early notable gainers among liquid option names on November 24th
10/23/20
Dollar Tree call volume above normal and directionally bullish
Hot Stocks
Kaleido Biosciences sees cash runway into 1Q22 » 07:38
03/03/21
03/03
07:38
03/03/21
07:38
KLDO

Kaleido Biosciences

$9.56 /

-0.12 (-1.24%)

As of December 31, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

01/14/21
Kaleido Biosciences announces interim results of controlled study of KB109
01/04/21
Kaleido Biosciences completes enrollment of 350 subjects in KB109 study
11/02/20
Kaleido Biosciences sees cash runway into 2H21
11/02/20
Kaleido Biosciences announces anticipated milestones
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
12/23/20 JMP Securities
Kaleido Biosciences initiated with an Outperform at JMP Securities
10/14/20 JPMorgan
Kaleido Biosciences resumed with an Underweight at JPMorgan
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

07:37 Today
Kaleido Biosciences reports Q4 EPS (56c), consensus (40c)
11/02/20
Kaleido Biosciences reports Q3 EPS (65c), consensus (63c)
  • 04
    Feb
  • 02
    Jun
03/17/21
Kaleido Biosciences - KLDO
03/19/21
Kaleido Biosciences
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

01/28/21
new option listings on January 28th
Hot Stocks
Tradeweb Markets reports February total trading volume $20.4T » 07:37
03/03/21
03/03
07:37
03/03/21
07:37
TW

Tradeweb Markets

$73.33 /

-0.44 (-0.60%)

Tradeweb Markets reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TW Tradeweb Markets
$73.33 /

-0.44 (-0.60%)

02/04/21
Tradeweb Markets reports $20T total volume traded in January
02/04/21
Tradeweb Markets sees FY21 CapEx $45M-$50M
02/02/21
Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M
02/02/21
Nasdaq to sell U.S. fixed income business to Tradeweb Markets
TW Tradeweb Markets
$73.33 /

-0.44 (-0.60%)

03/02/21 Morgan Stanley
Tradeweb Markets resumed with an Overweight at Morgan Stanley
02/22/21 Goldman Sachs
Tradeweb Markets upgraded to Buy from Neutral at Goldman Sachs
01/13/21 Compass Point
Tradeweb Markets upgraded in relative call against MarketAxess at Compass Point
01/13/21 Compass Point
Tradeweb Markets upgraded to Buy from Neutral at Compass Point
TW Tradeweb Markets
$73.33 /

-0.44 (-0.60%)

02/04/21
Tradeweb Markets reports Q4 adjusted EPS 34c, consensus 34c
10/28/20
Tradeweb Markets reports Q3 EPS 30c, consensus 29c
  • 23
    Apr
03/11/21
2021 Consumer, Industrials, & TMT Investor Virtual Conference
04/29/21
Tradeweb Markets - TW
Earnings
Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) » 07:37
03/03/21
03/03
07:37
03/03/21
07:37
KLDO

Kaleido Biosciences

$9.56 /

-0.12 (-1.24%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

01/14/21
Kaleido Biosciences announces interim results of controlled study of KB109
01/04/21
Kaleido Biosciences completes enrollment of 350 subjects in KB109 study
11/02/20
Kaleido Biosciences sees cash runway into 2H21
11/02/20
Kaleido Biosciences announces anticipated milestones
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

02/09/21 Piper Sandler
Kaleido Biosciences initiated with an Overweight at Piper Sandler
01/14/21 Chardan
Kaleido Biosciences price target raised to $17.50 from $10 at Chardan
12/23/20 JMP Securities
Kaleido Biosciences initiated with an Outperform at JMP Securities
10/14/20 JPMorgan
Kaleido Biosciences resumed with an Underweight at JPMorgan
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

11/02/20
Kaleido Biosciences reports Q3 EPS (65c), consensus (63c)
  • 04
    Feb
  • 02
    Jun
03/17/21
Kaleido Biosciences - KLDO
03/19/21
Kaleido Biosciences
KLDO Kaleido Biosciences
$9.56 /

-0.12 (-1.24%)

01/28/21
new option listings on January 28th
Options
Unusual call flow in option market yesterday » 07:36
03/03/21
03/03
07:36
03/03/21
07:36
RKT

Rocket Companies

$41.70 /

+17.4 (+71.60%)

, NLS

Nautilus

$20.46 /

+1.27 (+6.62%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

03/02/21
Rocket Companies soars as short interest gets highlighted
03/02/21
Rocket resumes trading after volatility halt, shares up 57% to $38.07
03/02/21
Rocket Companies trading resumes
03/02/21
Rocket Companies trading halted, volatility trading pause
NLS Nautilus
$20.46 /

+1.27 (+6.62%)

02/23/21
Nautilus falls -20.6%
02/22/21
Nautilus drops 8% to $24.50 after Q4 revenue misses consensus
02/22/21
Nautilus says demand for in-home fitness has not abated in 2021
12/30/20
Nautilus to change fiscal year to start in April and end in March
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

06:34 Today Zelman
Rocket Companies downgraded to Hold from Buy at Zelman
03/02/21 RBC Capital
Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital
03/02/21 Wells Fargo
Wells says Rocket Companies Q4 results 'not good enough to support' today's move
01/19/21 JPMorgan
JPMorgan double downgrades Rocket on more cautious mortgage stance
NLS Nautilus
$20.46 /

+1.27 (+6.62%)

11/10/20 Lake Street
Nautilus price target raised to $40 from $30 at Lake Street
11/10/20 Craig-Hallum
Nautilus price target raised to $28 from $22 at Craig-Hallum
10/15/20 Lake Street
Nautilus price target raised to $30 from $17 at Lake Street
10/14/20 Truist
Nautilus price target raised to $28 from $18 at Truist
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

02/25/21
Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c
02/25/21
Notable companies reporting after market close
11/10/20
Rocket Companies sees Q4 closed loan volume $88B-93B
11/10/20
Rocket Companies reports Q3 EPS 54c, consensus $1.09
NLS Nautilus
$20.46 /

+1.27 (+6.62%)

02/22/21
Nautilus sees Q1 net sales growth of 55%-75% over last year
02/22/21
Nautilus reports Q4 EPS 89c, consensus 75c
11/09/20
Nautilus sees FY20 revenue $540M-$565M, consensus $448.61M
11/09/20
Nautilus reports Q3 adjusted EPS 87c, consensus 32c
  • 06
    Aug
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

10/01/20
Realtor.com announces new partnership with Rocket Mortgage, Inman reports
NLS Nautilus
$20.46 /

+1.27 (+6.62%)

11/25/20
Peloton shipping delays may benefit Nautilus, WSJ reports
10/05/20
NordicTrack owner valued at over $7B in new funding round, Bloomberg says
09/09/20
Citron sets $30 target on Nautilus, predicts earnings 'blow out'
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

03/02/21
Fly Intel: Wall Street's top stories for Tuesday
02/25/21
Fly Intel: After-Hours Movers
11/10/20
Fly Intel: After-Hours Movers
NLS Nautilus
$20.46 /

+1.27 (+6.62%)

02/23/21
Fly Intel: Wall Street's top stories for Tuesday
02/23/21
Fly Intel: Wall Street's top stories at midday
02/23/21
Fly Intel: Pre-market Movers
02/22/21
Fly Intel: After-Hours Movers
RKT Rocket Companies
$41.70 /

+17.4 (+71.60%)

03/02/21
Callapalozza in Rocket Mortage echoes Gamestop squeeze
03/02/21
Unusually active option classes on open March 2nd
03/01/21
Rocket Companies call volume above normal and directionally bullish
03/01/21
Unusually active option classes on open March 1st
NLS Nautilus
$20.46 /

+1.27 (+6.62%)

03/02/21
Aggressive buyer sweeps October calls in Nautilus
11/09/20
Nautilus options imply 29.0% move in share price post-earnings
09/21/20
Nautilus call volume above normal and directionally bullish
09/09/20
Unusually active option classes on open September 9th
Earnings
Dollar Tree reports Q4 EPS $2.13, consensus $2.11 » 07:36
03/03/21
03/03
07:36
03/03/21
07:36
DLTR

Dollar Tree

$99.03 /

-0.16 (-0.16%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

02/16/21
SPAR Group appoints Mike Matacunas as president, CEO
02/04/21
Instacart announces new national delivery partnership with Family Dollar
12/07/20
Dollar Tree CEO sells 12.4K shares of common stock
12/03/20
Dollar Tree Director Thomas Saunders sells almost $12M in company shares
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

02/25/21
Fly Intel: Pre-market Movers
02/25/21 BofA
BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds
02/25/21 BofA
Dollar Tree downgraded to Underperform from Buy at BofA
02/16/21 JPMorgan
Dollar Tree price target raised to $134 from $130 at JPMorgan
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

11/24/20
Dollar Tree reports Q3 EPS $1.39, consensus $1.15
11/23/20
Notable companies reporting before tomorrow's open
11/23/20
Notable companies reporting before tomorrow's open
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

02/25/21
Lowe's, Square upgrades among today's top calls on Wall Street
11/24/20
Fly Intel: Wall Street's top stories for Tuesday
11/24/20
Fly Intel: Wall Street's top stories at midday
11/24/20
Fly Intel: Pre-market Movers
09:00 Today
Dollar Tree - DLTR
DLTR Dollar Tree
$99.03 /

-0.16 (-0.16%)

12/16/20
Early notable gainers among liquid option names on December 16th
11/24/20
Early notable gainers among liquid option names on November 24th
10/23/20
Dollar Tree call volume above normal and directionally bullish
Recommendations
Arena Pharmaceuticals price target lowered to $100 from $106 at Cantor Fitzgerald » 07:35
03/03/21
03/03
07:35
03/03/21
07:35
ARNA

Arena Pharmaceuticals

$76.67 /

-3.44 (-4.29%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

03/02/21
Arena Pharmaceuticals slides after IBS trial did not meet primary endpoint
03/02/21
Arena Pharmaceuticals reports topline results from Phase 2b CAPTIVATE trial
02/02/21
Arena Pharmaceuticals completes enrollment of ELEVATE UC 52 trial
12/08/20
Arena Pharmaceuticals achieves target enrollment for Phase 3 ELEVATE UC 52 trial
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

05:03 Today JonesTrading
Arena Pharmaceuticals price target lowered to $94 from $101 at JonesTrading
01/28/21 JonesTrading
Arena Pharmaceuticals initiated with a Buy at JonesTrading
11/19/20 SMBC Nikko
Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko
11/10/20 RBC Capital
Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

02/23/21
Arena Pharmaceuticals reports Q4 EPS ($2.10), consensus ($1.85)
11/09/20
Arena Pharmaceuticals reports Q3 EPS ($1.69), consensus ($1.87)
  • 28
    May
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

11/05/20
Governor Cuomo says NY 'ripe' for pot legalization, amNewYork says
11/04/20
Marijuana legalization measures set to pass in five states, Tech Crunch says
ARNA Arena Pharmaceuticals
$76.67 /

-3.44 (-4.29%)

03/02/21
Fly Intel: After-Hours Movers
11/10/20
Fly Intel: Wall Street's top stories for Tuesday
11/10/20
Fly Intel: Wall Street's top stories at midday
11/10/20
Fly Intel: Pre-market Movers
Hot Stocks
Strongbridge Biopharma sees 2021 KEVEYIS revenue $34M-$36M » 07:34
03/03/21
03/03
07:34
03/03/21
07:34
SBBP

Strongbridge Biopharma

$3.08 /

-0.08 (-2.53%)

Revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

07:33 Today
Strongbridge Biopharma expects cash to fund operations into 1Q23
07:33 Today
Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c)
03/02/21
Strongbridge Biopharma submits NDA for RECORLEV
02/16/21
iBio appoints Robert Lutz as CFO and CBO
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

09/08/20 JMP Securities
Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities
03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

01/06/21
Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M
01/06/21
Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M
01/06/21
Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M
10/29/20
Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c)
  • 17
    Sep
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

09/17/20
Fly Intel: Pre-market Movers
09/16/20
Fly Intel: After-Hours Movers
03/16/21
31st Annual Healthcare Virtual Conference
08:30 Today
Strongbridge Biopharma - SBBP
Hot Stocks
Ituran to distribute 48c per share cash dividend » 07:34
03/03/21
03/03
07:34
03/03/21
07:34
ITRN

Ituran

$21.44 /

-0.64 (-2.90%)

Ituran announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRN Ituran
$21.44 /

-0.64 (-2.90%)

07/21/20 Jefferies
Ituran downgraded to Hold on South America exposure at Jefferies
07/21/20 Jefferies
Ituran downgraded to Hold from Buy at Jefferies
09:00 Today
Ituran - ITRN
Hot Stocks
Jones Lang LaSalle launches commercial partnership, investment in Roofstock » 07:34
03/03/21
03/03
07:34
03/03/21
07:34
JLL

Jones Lang LaSalle

$178.34 /

-0.7 (-0.39%)

JLL announced a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$178.34 /

-0.7 (-0.39%)

02/17/21
JLL appoints Gilda Perez-Alvarado as global CEO, Hotels & Hospitality
01/25/21
JLL appoints Ingrid Jacobs as head of diversity, inclusion
11/24/20
BP, Jones Lang LaSalle enter multi-year vested workplace evolution agreement
11/20/20
JLL names Rastogi chief product officer to lead JLL Technologies
JLL Jones Lang LaSalle
$178.34 /

-0.7 (-0.39%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
JLL Jones Lang LaSalle
$178.34 /

-0.7 (-0.39%)

02/09/21
Jones Lang LaSalle reports Q4 adjusted EPS $5.29 vs. $6.35 a year ago
02/09/21
Jones Lang LaSalle reports Q4 adjusted EPS $5.29, consensus $3.93
11/02/20
Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25
11/02/20
Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25
10:00 Today
Jones Lang LaSalle - JLL
Hot Stocks
Strongbridge Biopharma expects cash to fund operations into 1Q23 » 07:33
03/03/21
03/03
07:33
03/03/21
07:33
SBBP

Strongbridge Biopharma

$3.08 /

-0.08 (-2.53%)

Assuming the availability…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

07:33 Today
Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c)
03/02/21
Strongbridge Biopharma submits NDA for RECORLEV
02/16/21
iBio appoints Robert Lutz as CFO and CBO
02/16/21
Strongbridge Biopharma appoints Richard Kollender as president, CFO
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

09/08/20 JMP Securities
Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities
03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

01/06/21
Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M
01/06/21
Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M
01/06/21
Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M
10/29/20
Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c)
  • 17
    Sep
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

09/17/20
Fly Intel: Pre-market Movers
09/16/20
Fly Intel: After-Hours Movers
03/16/21
31st Annual Healthcare Virtual Conference
08:30 Today
Strongbridge Biopharma - SBBP
Recommendations
HP Enterprise price target raised to $20 from $17 at BofA » 07:33
03/03/21
03/03
07:33
03/03/21
07:33
HPE

HP Enterprise

$14.51 /

-0.105 (-0.72%)

BofA analyst Wamsi Mohan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HPE HP Enterprise
$14.51 /

-0.105 (-0.72%)

01/27/21
HP Enterprise to build $35M+ supercomputer for NCAR
12/08/20
Verizon expands SD WAN portfolio with Silver Peak
12/01/20
HP Enterprise to relocate headquarters to Houston, Texas
11/17/20
Zuora announces Paul Heard as chief information officer
HPE HP Enterprise
$14.51 /

-0.105 (-0.72%)

01/15/21
Fly Intel: Top five analyst upgrades
01/15/21 JPMorgan
JPMorgan upgrades 'good contrarian long trade' HP Enterprise to Overweight
01/15/21 JPMorgan
HP Enterprise upgraded to Overweight from Neutral at JPMorgan
12/16/20 Morgan Stanley
HP Enterprise price target raised to $13.50 from $13 at Morgan Stanley
HPE HP Enterprise
$14.51 /

-0.105 (-0.72%)

03/02/21
HP Enterprise raises FY21 adjusted EPS view to $1.70-$1.88, consensus $1.67
03/02/21
HP Enterprise sees Q2 adjusted EPS 38c-44c, consensus 38c
03/02/21
HP Enterprise reports Q1 adjusted EPS 52c, consensus 41c
12/01/20
HP Enterprise sees Q1 revenue down mid-single digits from Q4
HPE HP Enterprise
$14.51 /

-0.105 (-0.72%)

12/02/20
Fly Intel: Wall Street's top stories for Wednesday
12/02/20
Fly Intel: Wall Street's top stories at midday
12/01/20
Fly Intel: After-Hours Movers
10/16/20
Fly Intel: Wall Street's top stories for Friday
03/11/21
2021 Consumer, Industrials, & TMT Investor Virtual Conference
04/14/21
Hewlett Packard Enterprise Co.
HPE HP Enterprise
$14.51 /

-0.105 (-0.72%)

12/01/20
Hewlett Packard Enterprise options imply 9.8% move in share price post-earnings
11/10/20
Hewlett Packard Enterprise put volume heavy and directionally bearish
10/14/20
Hewlett Packard Enterprise call volume above normal and directionally bullish
09/29/20
Hewlett Packard Enterprise put volume heavy and directionally bearish
Hot Stocks
Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) » 07:33
03/03/21
03/03
07:33
03/03/21
07:33
SBBP

Strongbridge Biopharma

$3.08 /

-0.08 (-2.53%)

Reports Q4 revenue $8.2M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

03/02/21
Strongbridge Biopharma submits NDA for RECORLEV
02/16/21
iBio appoints Robert Lutz as CFO and CBO
02/16/21
Strongbridge Biopharma appoints Richard Kollender as president, CFO
02/03/21
Strongbridge Biopharma announces employment inducement awards
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

09/08/20 JMP Securities
Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities
03/03/20
Fly Intel: Top five analyst initiations
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
03/03/20 Craig-Hallum
Strongbridge Biopharma initiated with a Buy at Craig-Hallum
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

01/06/21
Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M
01/06/21
Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M
01/06/21
Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M
10/29/20
Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c)
  • 17
    Sep
SBBP Strongbridge Biopharma
$3.08 /

-0.08 (-2.53%)

09/17/20
Fly Intel: Pre-market Movers
09/16/20
Fly Intel: After-Hours Movers
03/16/21
31st Annual Healthcare Virtual Conference
08:30 Today
Strongbridge Biopharma - SBBP
Recommendations
Kohl's price target raised to $67 from $65 at Cowen » 07:32
03/03/21
03/03
07:32
03/03/21
07:32
KSS

Kohl's

$57.36 /

+0.41 (+0.72%)

Cowen analyst Oliver Chen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$57.36 /

+0.41 (+0.72%)

03/02/21
Kohl's planning $200M-$300M in share repurchases in 2021
03/02/21
Kohl's plans to refresh approximately 675 stores over the next two years
03/02/21
Kohl's 'optimistic that brighter days are ahead'
03/02/21
Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023
KSS Kohl's
$57.36 /

+0.41 (+0.72%)

06:37 Today Citi
Kohl's price target raised to $67 from $56 at Citi
02/18/21 Morgan Stanley
Kohl's price target raised to $40 from $27 at Morgan Stanley
02/05/21 Baird
Kohl's price target raised to $58 from $48 at Baird
02/05/21 Deutsche Bank
Kohl's price target raised to $55 from $51 at Deutsche Bank
KSS Kohl's
$57.36 /

+0.41 (+0.72%)

03/02/21
Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43)
03/01/21
Notable companies reporting before tomorrow's open
03/01/21
Notable companies reporting before tomorrow's open
02/04/21
Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c
KSS Kohl's
$57.36 /

+0.41 (+0.72%)

02/22/21
Kohl's 'rejects' activist investor group attempt in statement to CNBC
02/21/21
Nine directors nominated to Kohl's board by activist investors, WSJ reports
09/21/20
Walmart to launch private label for men's and women's clothing, CNBC reports
KSS Kohl's
$57.36 /

+0.41 (+0.72%)

03/02/21
Fly Intel: Wall Street's top stories for Tuesday
03/02/21
Fly Intel: Wall Street's top stories at midday
03/02/21
Fly Intel: Pre-market Movers
02/22/21
Fly Intel: Wall Street's top stories for Monday
KSS Kohl's
$57.36 /

+0.41 (+0.72%)

01/11/21
Early notable gainers among liquid option names on January 11th
12/30/20
Early notable gainers among liquid option names on December 30th
12/18/20
Early notable gainers among liquid option names on December 18th
12/11/20
Kohl's put volume heavy and directionally bearish
Recommendations
Dine Brands price target raised to $90 from $85 at Raymond James » 07:32
03/03/21
03/03
07:32
03/03/21
07:32
DIN

Dine Brands

$78.83 /

-2.795 (-3.42%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIN Dine Brands
$78.83 /

-2.795 (-3.42%)

03/02/21
Dine Brands says Applebee's SSS improving roughly 8% QTD from January
03/02/21
Dine Brands sees FY21 capital expenditures $14M
11/17/20
Dine Brands names John Peyton, president and CEO
DIN Dine Brands
$78.83 /

-2.795 (-3.42%)

07:08 Today Barclays
Dine Brands price target raised to $95 from $80 at Barclays
02/10/21 Deutsche Bank
Dine Brands downgraded to Hold from Buy at Deutsche Bank
01/20/21 Wedbush
Dine Brands added to Best List Ideas, target raised to $83 at Wedbush
01/06/21 Raymond James
Dine Brands upgraded to Outperform from Market Perform at Raymond James
DIN Dine Brands
$78.83 /

-2.795 (-3.42%)

03/02/21
Dine Brands reports Q4 adjusted EPS 39c, consensus 67c
10/28/20
Dine Brands reports Q3 EPS 80c, consensus 36c
Hot Stocks
Dish, DraftKings announce strategic agreement » 07:32
03/03/21
03/03
07:32
03/03/21
07:32
DISH

Dish

$33.11 /

+0.26 (+0.79%)

, DKNG

DraftKings

$68.56 /

-0.14 (-0.20%)

DISH Network (DISH) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DISH Dish
$33.11 /

+0.26 (+0.79%)

02/23/21
ADT Inc., Dish partner to bring smart home security to more customers
02/22/21
Dish signs master lease agreement with SBA Communications
02/16/21
Dish announces seven new tower agreements
02/08/21
Dish selects Aviat Networks for 5G microwave wireless transport
DKNG DraftKings
$68.56 /

-0.14 (-0.20%)

02/26/21
DraftKings MUPs for B2C segment up 44% vs. 4Q19
02/25/21
Bill introduced in Florida Senate to authorize sports wagering
02/25/21
Nevada reports January statewide gaming win down 26.6% to $761.85M
02/25/21
DraftKings names Cal Ripken Jr. as special advisor to board of directors
DISH Dish
$33.11 /

+0.26 (+0.79%)

02/25/21 Oppenheimer
Verizon, AT&T downgraded to Perform on valuation at Oppenheimer
02/23/21
Fly Intel: Top five analyst downgrades
02/23/21 Pivotal Research
Dish downgraded to Hold from Buy at Pivotal Research
12/04/20 Guggenheim
Dish downgraded to Neutral from Buy at Guggenheim
DKNG DraftKings
$68.56 /

-0.14 (-0.20%)

03/01/21 Craig-Hallum
DraftKings price target raised to $70 from $65 at Craig-Hallum
03/01/21 Canaccord
DraftKings price target raised to $80 from $65 at Canaccord
03/01/21 Northland
DraftKings price target raised to $70 from $55 at Northland
03/01/21 Benchmark
DraftKings price target raised to $69 from $66 at Benchmark
DISH Dish
$33.11 /

+0.26 (+0.79%)

02/22/21
Dish reports Q4 EPS $1.24, consensus 75c
11/06/20
Dish reports Q3 EPS 86c, consensus 70c
DKNG DraftKings
$68.56 /

-0.14 (-0.20%)

02/26/21
DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M
02/26/21
DraftKings reports Q4 revenue $322M, consensus $232.6M
02/25/21
Notable companies reporting before tomorrow's open
02/25/21
Notable companies reporting before tomorrow's open
  • 07
    Oct
  • 19
    Jun
DISH Dish
$33.11 /

+0.26 (+0.79%)

11/18/20
Dish 'improperly' received $3.3B in spectrum discounts, FBN says
11/02/20
Dish offers services to DoD's proposed 5G network project, WSJ reports
10/15/20
Dish, DirecTV merger again squashed by DOJ, NY Post reports
10/06/20
AT&T's auction of DirecTV turning into a 'fire sale," NY Post says
DKNG DraftKings
$68.56 /

-0.14 (-0.20%)

03/02/21
Hedgeye adds DraftKings as a Best Idea Short
03/02/21
Connecticut, Mohegan Tribe reach deal on sports betting, The Day reports
02/12/21
Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says
02/09/21
TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says
DISH Dish
$33.11 /

+0.26 (+0.79%)

02/25/21
Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction
02/25/21
Lowe's, Square upgrades among today's top calls on Wall Street
02/23/21
Starbucks upgrade, Kroger downgrade among today's top calls on Wall Street
02/22/21
Fly Intel: Pre-market Movers
DKNG DraftKings
$68.56 /

-0.14 (-0.20%)

03/01/21
Fly Intel: Wall Street's top stories for Monday
02/26/21
Fly Intel: Wall Street's top stories for Friday
02/26/21
Bet On It: Florida and Texas trying to get in on the action
02/26/21
Fly Intel: Wall Street's top stories at midday
03/09/21
DraftKings Inc
DISH Dish
$33.11 /

+0.26 (+0.79%)

02/25/21
Early notable gainers among liquid option names on February 25th
02/04/21
Dish Network put volume heavy and directionally bearish
12/22/20
Unusual call flow in option market yesterday
12/21/20
Dish Network put volume heavy and directionally bearish
DKNG DraftKings
$68.56 /

-0.14 (-0.20%)

02/02/21
DraftKings call volume above normal and directionally bullish
01/27/21
DraftKings call volume above normal and directionally bullish
01/26/21
DraftKings call volume above normal and directionally bullish
01/12/21
DraftKings call volume above normal and directionally bullish
Downgrade
BankUnited downgraded to Neutral from Buy at Janney Montgomery Scott » 07:31
03/03/21
03/03
07:31
03/03/21
07:31
BKU

BankUnited

$42.03 /

-0.025 (-0.06%)

Janney Montgomery Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKU BankUnited
$42.03 /

-0.025 (-0.06%)

02/19/21 DA Davidson
BankUnited downgraded to Neutral from Buy at DA Davidson
02/19/21 DA Davidson
BankUnited downgraded to Neutral from Buy at DA Davidson
01/25/21 RBC Capital
BankUnited price target raised to $42 from $39 at RBC Capital
01/08/21 UBS
BankUnited downgraded to Neutral from Buy at UBS
BKU BankUnited
$42.03 /

-0.025 (-0.06%)

01/21/21
BankUnited reports Q4 EPS 89c, consensus 70c
10/28/20
BankUnited reports Q3 EPS 70c, consensus 63c
Upgrade
Itron upgraded to Buy from Hold at Argus » 07:29
03/03/21
03/03
07:29
03/03/21
07:29
ITRI

Itron

$117.75 /

-0.06 (-0.05%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$117.75 /

-0.06 (-0.05%)

02/17/21
Bsquare, Itron extend pact over industrial IoT innovation
01/19/21
Itron and Versant Power collaborate to modernize electricity grid in Maine
10/05/20
ON Semiconductor appoints Itron CEO Thomas Deitrich to board
10/05/20
Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module
ITRI Itron
$117.75 /

-0.06 (-0.05%)

07:19 Today Argus
Itron upgraded to Buy from Hold at Argus
02/25/21 Oppenheimer
Itron price target raised to $127 from $75 at Oppenheimer
01/08/21 Raymond James
Itron downgraded to Outperform from Strong Buy at Raymond James
01/08/21 Raymond James
Itron downgraded to Outperform from Strong Buy at Raymond James
ITRI Itron
$117.75 /

-0.06 (-0.05%)

02/24/21
Itron sees FY21 EPS $2.15-$2.55, consensus $2.26
02/24/21
Itron reports Q4 EPS 65c, consensus 30c
11/02/20
Itron reports Q3 EPS 61c, consensus 25c
03/08/21
Itron
Recommendations
Otis Worldwide price target raised to $77 from $75 at Cowen » 07:29
03/03/21
03/03
07:29
03/03/21
07:29
OTIS

Otis Worldwide

$65.46 /

+0.55 (+0.85%)

Cowen analyst Cai Von…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTIS Otis Worldwide
$65.46 /

+0.55 (+0.85%)

02/10/21
Otis Worldwide selected to supply elevators, escalators in three Canadian cities
01/11/21
Otis Worldwide recommends shareholders reject TRC Capital 'mini-tender' offer
01/11/21
CVS Health names Laurie Havanec as Chief People Officer
OTIS Otis Worldwide
$65.46 /

+0.55 (+0.85%)

10/07/20 JPMorgan
Otis Worldwide price target raised to $79 from $75 at JPMorgan
09/24/20 Wolfe Research
Otis Worldwide upgraded to Outperform from Peer Perform at Wolfe Research
09/24/20 JPMorgan
Otis Worldwide pullback due to 'unwarranted concerns,' says JPMorgan
07/29/20 Credit Suisse
Otis Worldwide price target raised to $66 from $55 at Credit Suisse
OTIS Otis Worldwide
$65.46 /

+0.55 (+0.85%)

02/01/21
Otis Worldwide sees FY21 adjusted EPS $2.67-$2.77, consensus $2.62
02/01/21
Otis Worldwide reports Q4 non-GAAP EPS 66c, consensus 59c
10/26/20
Otis Worldwide raises FY20 adj. EPS view to $2.42 from $2.20-$2.30
10/26/20
Otis Worldwide reports Q3 adj. EPS 69c, consensus 56c
OTIS Otis Worldwide
$65.46 /

+0.55 (+0.85%)

02/01/21
Fly Intel: Pre-market Movers
10/26/20
Fly Intel: Pre-market Movers
03/04/21
Otis Worldwide - OTIS
Hot Stocks
Anghami to list on Nasdaq New York via Vistas Media Acquisition Company merger » 07:28
03/03/21
03/03
07:28
03/03/21
07:28
VMAC

Vistas Media Acquisition Company

$10.25 /

+0.05 (+0.49%)

Anghami, a music…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Iridium upgraded to Outperform from Market Perform at Raymond James » 07:28
03/03/21
03/03
07:28
03/03/21
07:28
IRDM

Iridium

$39.45 /

-2.47 (-5.89%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRDM Iridium
$39.45 /

-2.47 (-5.89%)

02/19/21
Iridium CEO sells 62.1K shares of common stock
02/12/21
Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12
02/12/21
Iridium to replace Monolithic Power in S&P 400 at open on 2/12
02/10/21
Iridium board approves $300M share repurchase program
IRDM Iridium
$39.45 /

-2.47 (-5.89%)

04:40 Today Raymond James
Iridium upgraded to Outperform from Market Perform at Raymond James
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Barclays double downgrades Iridium with stock ahead of fundamentals
02/12/21 Barclays
Iridium downgraded to Underweight from Overweight at Barclays
IRDM Iridium
$39.45 /

-2.47 (-5.89%)

02/11/21
Iridium sees FY21 service revenue growth of 3%
02/11/21
Iridium reports Q4 EPS (6c), consensus (8c)
10/20/20
Iridium reports Q3 EPS (3c), consensus (11c)
Recommendations
Ambarella price target raised to $137 from $125 at Morgan Stanley » 07:27
03/03/21
03/03
07:27
03/03/21
07:27
AMBA

Ambarella

$113.78 /

-4.91 (-4.14%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

03/02/21
Ambarella jumps 7% to $121.95 after Q4 results top estimates
03/02/21
Motional selects Ambarella CVflow AI processors for driverless vehicles
01/11/21
Ambarella unveils CV5 AI vision processor with 8K capabilities
12/28/20
FAA adopts final rules for drones 'advancing opportunities' for utilization
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

07:12 Today Stifel
Ambarella price target raised to $135 from $128 at Stifel
02/24/21 Deutsche Bank
Ambarella price target raised to $100 from $75 at Deutsche Bank
01/21/21 Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

03/02/21
Ambarella reports Q4 EPS 14c, consensus 8c
11/24/20
Ambarella sees Q4 revenue $56M-$60M, consensus $52.31M
11/23/20
Ambarella reports Q3 EPS 9c, consensus 5c
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

03/02/21
Fly Intel: After-Hours Movers
12/14/20
Fly Insider: Molecular Templates, AMD among notable insider trades
12/07/20
Fly Insider: Foot Locker, Alexion among weeks notable insider trades
11/23/20
Fly Intel: After-Hours Movers
03/15/21
33rd Annual Roth Virtual Conference
AMBA Ambarella
$113.78 /

-4.91 (-4.14%)

02/01/21
Ambarella call volume above normal and directionally bullish
01/21/21
Ambarella call volume above normal and directionally bullish
12/10/20
Ambarella call volume above normal and directionally bullish
12/03/20
Ambarella call volume above normal and directionally bullish
Recommendations
Columbia Sportswear price target raised to $130 from $116 at Cowen » 07:27
03/03/21
03/03
07:27
03/03/21
07:27
COLM

Columbia Sportswear

$102.64 /

-2.6 (-2.47%)

Cowen analyst John Kernan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COLM Columbia Sportswear
$102.64 /

-2.6 (-2.47%)

02/04/21
Columbia Sportswear board approves $400M share buyback increase
02/04/21
Columbia Sportswear restores 26c per share quarterly dividend
01/27/21
Columbia Sportswear names Skip Potter as Chief Digital Information Officer
01/06/21
Columbia Sportswear names Starbucks' John Culver to board of directors
COLM Columbia Sportswear
$102.64 /

-2.6 (-2.47%)

02/05/21 Baird
Columbia Sportswear price target raised to $120 from $98 at Baird
12/09/20 BofA
Columbia Sportswear cut to Neutral at BofA on more challenging near-term view
12/09/20 BofA
Columbia Sportswear downgraded to Neutral from Buy at BofA
10/30/20 Baird
Columbia Sportswear weakness a buying opportunity, says Baird
COLM Columbia Sportswear
$102.64 /

-2.6 (-2.47%)

02/04/21
Columbia Sportswear sees FY21 $3.75-$4.05 EPS , consensus $3.65
02/04/21
Columbia Sportswear reports Q4 EPS $1.44, consensus $1.24
02/04/21
Notable companies reporting after market close
10/29/20
Columbia Sportswear sees Q4 EPS $1.07-$1.32, consensus $1.59
COLM Columbia Sportswear
$102.64 /

-2.6 (-2.47%)

10/22/20
Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear
COLM Columbia Sportswear
$102.64 /

-2.6 (-2.47%)

02/04/21
Fly Intel: After-Hours Movers
12/28/20
Fly Insider:180 Degree Capital, AMC among week's notable insider trades
10/29/20
Fly Intel: After-Hours Movers

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.